Related Experiment Video
Updated: Jan 26, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
An ATG5 knockout promotes paclitaxel resistance in v-Ha-ras-transformed NIH 3T3 cells
Seong Yun Eom1, Sung-Hee Hwang1, Hojin Yeom1
1Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, 22012, Republic of Korea.
Abstract:
Autophagy plays a contradictory role in cell survival and death. Here, we investigated changes in paclitaxel sensitivity of cells with an ATG5 gene-knockout (KO), incapable of synthesizing an E3 ubiquitin ligase necessary for autophagy. The ATG5 KO in v-Ha-ras-transformed NIH 3T3 cells (Ras-NIH 3T3) was established using the CRISPR/Cas9 system. An LC3 immunoblot and a qRT-PCR assay were used to confirm the KO of functional ATG5. We found that the ATG5 KO led to paclitaxel resistance in Ras-NIH 3T3 cells through an ATP-binding cassette (ABC) transporter-independent mechanism. Flow cytometric analyses revealed that paclitaxel induced a remarkable significant G2/M arrest in parental cells, whereas it was relatively less effective in ATG5 KO cells. Additionally, the proportion of early apoptotic cells significantly decreased in ATG5 KO cells treated with paclitaxel than in parental cells. Interestingly, overexpression of ATG5 N-terminal cleavage product in ATG5 KO cells restored their sensitivity to paclitaxel. Taken together, our results suggest that ATG5 KO cells are resistant to paclitaxel due to the inability to produce tATG5.
Insights
Autophagy gene ATG5 knockout (KO) confers paclitaxel resistance in cancer cells. This resistance is linked to the inability to produce a key autophagy protein, impacting cell cycle arrest and apoptosis.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Autophagy, a cellular degradation process, has complex roles in cell survival and death.
- ATG5 (autophagy related 5) is crucial for autophagosome formation, a key step in autophagy.
- Paclitaxel is a widely used chemotherapy drug that induces cell cycle arrest and apoptosis.
Purpose of the Study:
- To investigate the role of ATG5 in paclitaxel sensitivity.
- To determine if ATG5 knockout affects paclitaxel-induced cell cycle arrest and apoptosis.
- To explore the mechanism underlying ATG5-mediated paclitaxel resistance.
Main Methods:
- CRISPR/Cas9 gene editing to create ATG5 knockout (KO) Ras-NIH 3T3 cells.
- LC3 immunoblot and qRT-PCR to confirm ATG5 gene knockout.
- Flow cytometry to analyze cell cycle distribution and apoptosis.
- Overexpression of ATG5 cleavage product to assess functional restoration.
Main Results:
- ATG5 knockout rendered Ras-NIH 3T3 cells resistant to paclitaxel via an ATP-binding cassette transporter-independent mechanism.
- Paclitaxel induced less G2/M cell cycle arrest in ATG5 KO cells compared to parental cells.
- The proportion of early apoptotic cells was significantly reduced in ATG5 KO cells treated with paclitaxel.
- Restoration of ATG5 N-terminal cleavage product re-sensitized ATG5 KO cells to paclitaxel.
Conclusions:
- ATG5 is essential for paclitaxel sensitivity in Ras-NIH 3T3 cells.
- ATG5 knockout-mediated paclitaxel resistance is associated with impaired G2/M arrest and reduced apoptosis.
- The inability to produce the truncated ATG5 (tATG5) protein is responsible for paclitaxel resistance in ATG5 KO cells.
Related Concept Videos
The Ras Gene
Ras is a...
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Eukaryotic Promoter Region
Resistivity
Resistance

